Institut Universitaire de Cardiologie et de Pneumologie de Québec
Québec, Quebec, G1V4G5, Canada
NCT Number: NCT05819164
The oximeter is an instrument for monitoring patients receiving oxygen therapy. It displays pulse oxygen saturation (SpO2), which is a reflection of arterial oxygen saturation (SaO2). An accurate SpO2 value is essential for optimal management of the O2 flow delivered to patients. Several factors can influence this measurement and the choice of ventilatory support: the type of oximeter used, skin pigmentation and the oxygenation goal.
The objective of our study is to evaluate the impact of the oxygenation goal and the oximeter used on oxygen flows in patients with COPD (or with hypercapnia, or at risk of hypercapnia) and in patients without COPD (in particular pneumonia, pulmonary fibrosis and other pathologies) Our hypothesis is that the SpO2 target and oximeter used will have an impact on oxygen flows and that these effects will be synergistic in these different populations.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Québec, Quebec, G1V4G5, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During this period, the Masimo oximeter Radical 7 was used for SpO2 reading
During this period, the Nellcor oximeter N-600 was used for SpO2 reading
During this period, the Nonin oximeter was used for SpO2 reading
Time frame: assessed up to 10 minutes
the mean oxygen flow to reach the SpO2 target +/- 1% during 2 minutes for each period and each oximeter
Time frame: assessed up to 10 minutes - until SpO2 target stability for 2 minutes
Rate of partial oxygen weaning (Oxygen flow <=0.5 L/min) to reach the SpO2 target for each period and each oximeter
Time frame: assessed up to 10 minutes - until SpO2 target stability for 2 minutes
Rate of complete oxygen weaning (Oxygen flow <=0.1 L/min) to reach the SpO2 target for each period and each oximeter
Time frame: assessed up to 10 minutes - until SpO2 target stability for 2 minutes
Rate of high oxygen flow (Oxygen flow >5.0 L/min) to reach the SpO2 target for each period and each oximeter
Time frame: assessed up to 10 minutes - until SpO2 target stability for 2 minutes
the mean bias between the result of the different oximeter
Laval University
Other
Comparison of Multiple Oxygenation Targets With Different Oximeters in COPD and Non-COPD Patients- Impact on Oxygen Flows
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03119727
Asthma, Bronchial Diseases
Québec, Quebec, Canada
View Trial DetailsNCT04481555
Azithromycin, COPD
Aarhus, Denmark
View Trial DetailsNCT06156462
Asthma Exacerbation, COPD Exacerbation
London, United Kingdom
View Trial DetailsNCT05564156
COPD Asthma, COPD Exacerbation
Istanbul, Turkey (Türkiye)
View Trial Details